Previous close | 139.15 |
Open | 141.35 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 140.00 - 142.83 |
52-week range | 71.57 - 142.83 |
Volume | |
Avg. volume | 1,554 |
Market cap | 239.533M |
Beta (5Y monthly) | 1.05 |
PE ratio (TTM) | 0.17 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Comprehensive Analysis of Financial Performance and Market Position
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 21.43% and 2.01%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Improvement in revenue per treatment and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the first quarter.